Narcolepsy Disrupts™ (Avadel Pharmaceuticals and Fingerpaint)
Because narcolepsy affects daily activities such as school, work, family relationships, or social interactions, it is understandable that HCPs and patients mainly talk about the daytime effects of the condition. However, narcolepsy is a chronic, lifelong, 24/7 condition involving disordered sleep cycles. Treatment, while often helpful, can also add burden to a patient’s life as some medications currently require patients to take doses in the middle of the night.
Fingerpaint’s Narcolepsy Disrupts campaign explores the “swirl” that narcolepsy patients live with. It reveals ways patients juggle symptoms and treatment—all day and all night. The swirl is constant and overwhelming.
The impact was far-reaching. The initial HCP display campaign earned 744,038 impressions with a click-through rate of 0.20%—double the industry benchmark. The patient campaign saw over two million impressions and a click-through rate four times the industry benchmark. Since launch, it has reached almost 639,000 users on Facebook.
